| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/19/2013 | CN103159836A Compound biological agent for blocking human immunodeficiency virus (HIV) viruses from being replicated and being integrated with deoxyribonucleic acid (DNA) of host cell |
| 06/19/2013 | CN103159835A Lys and oligopeptide-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159832A Peptide with neuroprotective effect, preparation method thereof, pharmaceutical composition and purpose |
| 06/19/2013 | CN103159831A Pentapeptide, polypeptide, cyclopeptide derivative, compound and medicament and application of pentapeptide |
| 06/19/2013 | CN103159830A Lipopeptide compounds |
| 06/19/2013 | CN103159828A 1-(4-hydroxy-3-methoxycarbonyl)-beta-carboline-3-formyl tryptophyl amino acid benzyl ester, and synthesis and application thereof |
| 06/19/2013 | CN103159827A Synthesis, anti-thrombotic activity, and application of (1R, 3S) -1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid |
| 06/19/2013 | CN103159826A Lys and Lys (Pro-Ala-Lys)-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103157116A Novel cancer suppressor gene UNC5D and new applications of encoded protein thereof |
| 06/19/2013 | CN103157099A Mixed enzyme digestive juice for fast digestion of vascular adventitia and preparation method thereof |
| 06/19/2013 | CN103157098A Research for coordinate regulation for microtubule cytoskeleton structure and microfilament cytoskeleton structure and promotion for muscular contraction of UNC-51 kinase |
| 06/19/2013 | CN103157097A Medicinal liquid for improving eye fatigue |
| 06/19/2013 | CN103157096A Teriparatide sustained-release microsphere and preparation method thereof |
| 06/19/2013 | CN103157095A Kidney bean phytolectin applications in preparation of human drugs and drug composition thereof |
| 06/19/2013 | CN103157094A Pantoprazole sodium medicine composition for injection and preparation method thereof |
| 06/19/2013 | CN103156884A Functions of seminal plasma |
| 06/19/2013 | CN103156806A Thymalfasin in-situ gel preparation and preparation method thereof |
| 06/19/2013 | CN102617723B Scorpion venom active peptides, preparation method thereof and application |
| 06/19/2013 | CN102516365B Anti-HIV (human immunodeficiency virus) polypeptide of Tibetan dolphin scorpion |
| 06/19/2013 | CN102351948B Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3 |
| 06/19/2013 | CN102304171B Three alpha-conus polypeptides and use thereof |
| 06/19/2013 | CN102286079B Alpha type conotoxin peptides and applications thereof |
| 06/19/2013 | CN102260698B PTA-linker-thanatin fusion protein expressed in escherichia coli, and anticancer research thereof |
| 06/19/2013 | CN102250127B Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof |
| 06/19/2013 | CN102212126B Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity |
| 06/19/2013 | CN102199587B Functional mutant of human plasminogen, its preparation method and application |
| 06/19/2013 | CN102125686B Application of hard clam polypeptide |
| 06/19/2013 | CN102070712B VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
| 06/19/2013 | CN101970462B Cyclic compound and salt thereof |
| 06/19/2013 | CN101906144B Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof |
| 06/19/2013 | CN101899116B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 06/19/2013 | CN101883570B Synthesis of beta-nucleosides |
| 06/19/2013 | CN101766807B Injection packaging preparation of thymosin alpha1 microspheres |
| 06/19/2013 | CN101678082B Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 06/19/2013 | CN101602793B Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof |
| 06/19/2013 | CN101580538B WT1-origin HLA-DR-binding antigen peptide |
| 06/19/2013 | CN101573125B Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
| 06/19/2013 | CN101514232B RANKL-Fc fusion protein, preparation method and application thereof |
| 06/19/2013 | CN101505608B Polyphenol/peptide composition |
| 06/19/2013 | CN101466835B Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 06/19/2013 | CN101432428B Recombinant human interferon-like proteins |
| 06/18/2013 | US8466326 Production method for ubiquinone powder for use in preparations and product thereof |
| 06/18/2013 | US8466267 Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene |
| 06/18/2013 | US8466261 Therapeutic using a bispecific antibody |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466126 Composition and methods for promoting lush hair growth |
| 06/18/2013 | US8466112 Compositions comprising Ornithine Ketoglutarate (OKG) |
| 06/18/2013 | US8466111 Cyclopenta{G}quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 06/18/2013 | US8466110 Use of an agent that restores tissue perfusion and oxygenation |
| 06/18/2013 | US8466109 Applying in a suitable vehicle, at least one soya peptide for reducing the formation of and/or treating skin stretchmarks in a women during or after pregnancy or after puberty |
| 06/18/2013 | US8466108 TFPI inhibitors and methods of use |
| 06/18/2013 | US8466107 Fibrin-binding peptides and conjugates thereof |
| 06/18/2013 | US8466106 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
| 06/18/2013 | US8466104 Therapeutically active alpha MSH analogues |
| 06/18/2013 | US8466103 Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same |
| 06/18/2013 | US8466102 Antimicrobial cationic peptides and formulations thereof |
| 06/18/2013 | US8466101 Purified EMD protein composition |
| 06/18/2013 | US8465750 Staphylococcus aureus proteins and nucleic acids |
| 06/18/2013 | US8465747 Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy |
| 06/18/2013 | US8465746 Compositions and methods for treatment, research and therapeutic applications for malaria |
| 06/18/2013 | US8465736 Glutadon |
| 06/18/2013 | US8465735 Variant form of urate oxidase and use thereof |
| 06/18/2013 | US8465734 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/18/2013 | US8465468 Intradermal delivery of substances |
| 06/18/2013 | US8464706 Drug delivery apparatus |
| 06/18/2013 | CA2534895C Hemostatic compositions containing sterile thrombin |
| 06/18/2013 | CA2483102C Treatment and prevention of pulmonary conditions |
| 06/18/2013 | CA2481512C Peptide inhibitors of protein kinase c.gamma. for pain management |
| 06/18/2013 | CA2463459C Novel use of pulmonary surfactant |
| 06/18/2013 | CA2446087C Recombinant tumor specific antibody and use thereof |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/18/2013 | CA2267077C Methods for treating skin pigmentation |
| 06/13/2013 | WO2013086493A1 Compositions and methods for the generation of activated protein c and methods of use thereof |
| 06/13/2013 | WO2013086459A1 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants |
| 06/13/2013 | WO2013086331A1 High efficiency di-nucleotide cyclase |
| 06/13/2013 | WO2013086292A1 Glucagon formulations |
| 06/13/2013 | WO2013086228A1 Pegylated aspartyl-trna synthetase polypeptides |
| 06/13/2013 | WO2013086216A1 Improved aspartyl-trna synthetases |
| 06/13/2013 | WO2013086143A1 Modified mini-hepcidin peptides and methods of using thereof |
| 06/13/2013 | WO2013086020A1 Aromatic-cationic peptides and uses of same |
| 06/13/2013 | WO2013086003A1 Antimicrobial agent, bacterial strain, biosynthesis, and methods of use |
| 06/13/2013 | WO2013085902A1 Combination therapy methods for treating an inflammatory breast cancer |
| 06/13/2013 | WO2013085059A1 Method for producing nutritional composition |
| 06/13/2013 | WO2013084244A1 Stable lactase drops |
| 06/13/2013 | WO2013084236A1 Diagnostic and therapeutic methods and their application in amyotrophic lateral sclerosis (als) |
| 06/13/2013 | WO2013083858A1 Compounds suitable for treatment of haemophilia |
| 06/13/2013 | WO2013083695A1 Compositions for preventing or treating adverse reactions of egfr inhibition |
| 06/13/2013 | WO2013083605A1 Triptorelin pharmaceutical composition |
| 06/13/2013 | WO2013083574A1 Composition for treating parkinson's disease. |
| 06/13/2013 | WO2013083459A1 Robust controlled-release peptide formulations |
| 06/13/2013 | WO2013083338A1 New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus |
| 06/13/2013 | WO2013083041A1 Microspheres for controlled- or sustained-release delivery of therapeutics |
| 06/13/2013 | WO2013082875A1 Arsenic compound solution and albumin nanoparticle and lyophilized preparation entrapping arsenic compound prepared using same |
| 06/13/2013 | WO2013082667A1 Use of growth hormone fragments |
| 06/13/2013 | WO2013058833A8 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 06/13/2013 | WO2013056132A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 06/13/2013 | WO2013055888A3 Recombinant human naglu protein and uses thereof |
| 06/13/2013 | WO2013055058A9 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 06/13/2013 | WO2013051900A3 Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof |